Amarin Corp Plc\ukAMRN

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$13.20
Market cap
$276.8M
P/E
—
Revenue (TTM)
$186.2M
Net income
-$27.1M
Dividend yield
—
1-year total return
-14.6%
Net margin
-14.6%
Revenue growth
-15.1%
Debt / equity
—

What Amarin Corp Plc\uk does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$614.1M$583.2M$369.2M$306.9M$228.6M$213.6M
Net income-$18.0M$7.7M-$105.8M-$59.1M-$82.2M-$38.8M
Free cash flow-$22.0M—————

More on AMRN.

Figures from Amarin Corp Plc\uk's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.